Related Experiment Video
Updated: Jun 4, 2026

10:06
Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry
Published on: March 24, 2023
Texaphyrins: tumor localizing redox active expanded porphyrins
Jonathan F Arambula1, Christian Preihs, Derric Borthwick
1Department of Chemistry and Biochemistry, The University of Texas at Austin, Austin, TX 78712-0165, USA.
Anti-Cancer Agents in Medicinal Chemistry
|March 2, 2011
Summary
Texaphyrins, tumor-selective compounds, show promise as redox mediators in cancer chemotherapy. Research explores their mechanisms, structure-activity relationships, and applications in targeted drug delivery for enhanced cancer treatment.
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Oncology
Background:
- Texaphyrins are tumor-selective expanded porphyrins.
- They can coordinate large metals and act as redox mediators.
- Their potential in cancer therapy is under investigation.
Purpose of the Study:
- To review experimental uses of texaphyrins in cancer chemotherapy.
- To describe mechanistic insights and structure-activity relationships.
- To present novel texaphyrin applications in targeted drug delivery.
Main Methods:
- Literature review of experimental studies.
- Analysis of mechanistic data.
- Examination of structure-activity relationships.
- Summary of recent advancements in drug delivery.
Main Results:
- Texaphyrins demonstrate redox mediator activity in biological systems.
- Experimental data supports their use in cancer chemotherapy.
- Structure-activity relationships provide insights into their efficacy.
- Emerging applications involve targeted drug delivery strategies.
Conclusions:
- Texaphyrins are a promising class of compounds for cancer treatment.
- Further research into their mechanisms and applications is warranted.
- Texaphyrin-based targeted drug delivery holds significant therapeutic potential.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...

